Cleanroom Technology Market to be Worth $5.6 Billion by 2030: Grand View Research, Inc.

SAN FRANCISCO, May 17, 2023 /PRNewswire/ — The global cleanroom technology market size is expected to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.58% from 2023 to 2030. Growing compliance with stringent regulatory standards for new product … Read more

Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases

Uniting to Combat Neglected Tropical Diseases (unitingtocombatntds.org) releases letter signed by 36 Parliamentarians from 23 countries calling on G7 Leaders to invest in NTDs. LONDON, May 17, 2023 /PRNewswire/ — To: Fumio Kishida, Prime Minister, Japan (Host) Joe Biden, President, United StatesEmmanuel Macron, President, FranceGiorgia Meloni, Prime Minister, ItalyOlaf Scholz, Chancellor, GermanyRishi Sunak, Prime Minister, … Read more

Invitation to Immunovia’s Q1 presentation

LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more

Invitation to Immunovia’s Q1 presentation

LUND, Sweden, May 17, 2023 /PRNewswire/ — Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com Jeff Borcherding, CEO … Read more

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023.  This year’s report … Read more

New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine

Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023.  This year’s report … Read more

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator in wound care technology, proudly announces the release of newly published expert recommendations on the use of topical oxygen therapy for wound healing1. The updated … Read more

New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy for Diabetic Foot Ulcers

Evidence-based recommendations support the effective use of TOT in diabetic foot ulcer management, revolutionizing treatment approaches worldwide CAMBRIDGE, England, May 17, 2023 /PRNewswire/ — NATROX® Wound Care, a leading innovator in wound care technology, proudly announces the release of newly published expert recommendations on the use of topical oxygen therapy for wound healing1. The updated … Read more

RaySearch Laboratories: Interim report January 1

STOCKHOLM, May 17, 2023 /PRNewswire/ —  FIRST QUARTER (JANUARY – MARCH 2023) Order intake SEK 206.6 M (272.5) Net sales SEK 230.2 M (208.1) Operating profit SEK 23.7 M (29.6) Profit after tax SEK 17.6 M (19.3) Earnings per share before/after dilution SEK 0.51 (0.56) Cash flow SEK 84.5 M (35.3) Order backlog SEK 1,903.3 … Read more

Inclusion of Recbio In the MSCI China Small Cap Index

TAIZHOU, China, May 17, 2023 /PRNewswire/ — Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that, MSCI announced the results of the semi-annual review of the MSCI Global Small Cap Indexes on May 12, 2023, and the Company has been selected as a constituent of the … Read more